1. Home
  2. NNNN vs HYLN Comparison

NNNN vs HYLN Comparison

Compare NNNN & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$16.79

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Hyliion Holdings Corp.

HYLN

Hyliion Holdings Corp.

HOLD

Current Price

$8.19

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
HYLN
Founded
2021
2018
Country
Germany
United States
Employees
27
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NNNN
HYLN
Price
$16.79
$8.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
21.2K
6.9M
Earning Date
04-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,475,000.00
Revenue This Year
N/A
$197.93
Revenue Next Year
N/A
$301.97
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
130.28
52 Week Low
$10.50
$1.31
52 Week High
$55.65
$8.22

Technical Indicators

Market Signals
Indicator
NNNN
HYLN
Relative Strength Index (RSI) 33.36 68.60
Support Level $14.66 $1.79
Resistance Level $31.12 N/A
Average True Range (ATR) 3.11 0.98
MACD -0.97 -0.05
Stochastic Oscillator 9.95 79.27

Price Performance

Historical Comparison
NNNN
HYLN

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.

Share on Social Networks: